Is specialized palliative cancer care associated with use of antineoplastic treatment at the end of life? A population-based cohort study.

Kirstine Skov Benthien Mathilde AdsersenMorten Aagaard PetersenEva Soelberg VadstrupPer SjøgrenMogens Groenvold

Published in: Palliative medicine (2018)

Overall, the incidence of antineoplastic treatment in the last 14 days of life was low compared to other studies. Patients in specialized palliative care had a reduced risk of receiving chemotherapy at the end of life.

Keyphrases

palliative care
end stage renal disease
advanced cancer
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
prognostic factors
peritoneal dialysis
patient reported outcomes
combination therapy